NASDAQ:CWBR CohBar (CWBR) Stock Price, News & Analysis → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free CWBR Stock Alerts $0.80 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.80▼$0.8050-Day Range$0.76▼$1.0052-Week Range$0.51▼$6.90Volume7 shsAverage Volume1,006 shsMarket Capitalization$2.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get CohBar alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About CohBar Stock (NASDAQ:CWBR)CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.Read More CWBR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CWBR Stock News HeadlinesApril 18, 2024 | americanbankingnews.comCohBar (NASDAQ:CWBR) Stock Price Up 12.5%April 16, 2024 | finance.yahoo.comCohBar, Inc. (CWBR)April 25, 2024 | WealthPress (Ad)It’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. January 23, 2024 | morningstar.comNorth American Morning Briefing: Stock Futures Steady as Earnings Season Ramps UpJanuary 19, 2024 | morningstar.comCohBar Inc CWBRJanuary 9, 2024 | morningstar.comNorth American Morning Briefing: Samsung Warning Knocks Tech StocksNovember 29, 2023 | benzinga.comCohBar Stock (NASDAQ:CWBR) Dividends: History, Yield and DatesNovember 28, 2023 | msn.comCohBar announces Nasdaq's notice of delisting; does not plan to request hearingApril 25, 2024 | WealthPress (Ad)It’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. November 1, 2023 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.67%November 1, 2023 | benzinga.comWhy CohBar (CWBR) Stock Is Down Nearly 50% TodayAugust 15, 2023 | finanznachrichten.deCohBar, Inc.: CohBar Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comCohBar Reports Second Quarter 2023 Financial ResultsJuly 17, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WTT, CWBR, DMJune 29, 2023 | markets.businessinsider.comIMPORTANT ALERT: Halper Sadeh LLC Investigates PDCE, CWBR, EMAN, HMPTJune 5, 2023 | msn.comCohBar's Acquisition Partner Touts Encouraging Data From Personalized Cancer VaccineJune 3, 2023 | benzinga.comLifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECTMay 31, 2023 | benzinga.comCOHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBRMay 30, 2023 | finance.yahoo.comMorphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 25, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CohBar, Inc. MergerMay 24, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.May 24, 2023 | msn.comWhy Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketMay 23, 2023 | msn.comCohBar Almost Quadruples amid Morphogenesis MergerMay 23, 2023 | benzinga.comCohBar Stock Doubles: Company Agrees To Merge With Morphogenesis To Advance Late-Stage Oncology CandidatesMay 23, 2023 | investorplace.comWhy Is CohBar (CWBR) Stock Up 130% Today?May 23, 2023 | marketwatch.comCohbar to Merge with Morphogenesis; Combined Company to Be Called TuHURA BiosciencesMay 23, 2023 | technews.tmcnet.comCWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to ShareholdersSee More Headlines Receive CWBR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CohBar and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today4/25/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CWBR CUSIPN/A CIK1522602 Webwww.cohbar.com Phone(650) 446-7888FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$5.27 per share Price / Book0.15Miscellaneous Outstanding Shares2,910,000Free Float2,718,000Market Cap$2.33 million OptionableNot Optionable Beta1.54 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Pinchas Cohen Dean (Age 67)M.D., Founder & Member of Scientific Advisory Board Comp: $65.25kDr. Nir Yacov Barzilai M.D. (Age 68)Founder & Member of Scientific Advisory Board Comp: $65.25kDr. John M. Amatruda M.D. (Age 78)Ph.D., Co-Founder Comp: $31.5kMs. Jordyn TaraziDirector of Investor RelationsKey CompetitorsOnconetixNASDAQ:ONCOTransCode TherapeuticsNASDAQ:RNAZAgile TherapeuticsNASDAQ:AGRXNovaBay PharmaceuticalsNYSE:NBYAltamira TherapeuticsNASDAQ:CYTOView All CompetitorsInstitutional OwnershipRVW Wealth LLCSold 5,263,213 shares on 4/8/2024Ownership: 6.237%View All Institutional Transactions CWBR Stock Analysis - Frequently Asked Questions How have CWBR shares performed in 2024? CohBar's stock was trading at $0.74 at the start of the year. Since then, CWBR stock has increased by 8.1% and is now trading at $0.80. View the best growth stocks for 2024 here. When is CohBar's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our CWBR earnings forecast. How were CohBar's earnings last quarter? CohBar, Inc. (NASDAQ:CWBR) issued its quarterly earnings data on Monday, November, 15th. The company reported ($1.50) earnings per share for the quarter, beating analysts' consensus estimates of ($2.70) by $1.20. During the same period in the prior year, the business posted ($1.20) EPS. When did CohBar's stock split? Shares of CohBar reverse split on the morning of Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of CohBar own? Based on aggregate information from My MarketBeat watchlists, some companies that other CohBar investors own include Strongbridge Biopharma (SBBP), ZIOPHARM Oncology (ZIOP), AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX) and DURECT (DRRX). Who are CohBar's major shareholders? CohBar's stock is owned by many different retail and institutional investors. Top institutional investors include RVW Wealth LLC (6.24%). Insiders that own company stock include Joseph J Sarret, Kenneth C Cundy and Misha Petkevich. View institutional ownership trends. How do I buy shares of CohBar? Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CWBR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
